PE20030933A1 - Sales del acido cinamico, procedimientos para su preparacion y su utilizacion como medicamentos - Google Patents
Sales del acido cinamico, procedimientos para su preparacion y su utilizacion como medicamentosInfo
- Publication number
- PE20030933A1 PE20030933A1 PE2003000197A PE2003000197A PE20030933A1 PE 20030933 A1 PE20030933 A1 PE 20030933A1 PE 2003000197 A PE2003000197 A PE 2003000197A PE 2003000197 A PE2003000197 A PE 2003000197A PE 20030933 A1 PE20030933 A1 PE 20030933A1
- Authority
- PE
- Peru
- Prior art keywords
- benzenodimethanol
- phenylbutoxy
- hexyl
- hydroxy
- methyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 4
- 239000002253 acid Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- -1 4-PHENYLBUTOXY Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 229960004017 salmeterol Drugs 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A SALES DEL ACIDO CINAMICO DEL SALMETEROL DE FORMULA I; CARACTERIZADA POR EL ALTO GRADO DE COMPATIBILIDAD LOCAL, DONDE R1 Y R2 SON H, ALQUILO, ALCOXI, HALOGENO, CF3, FENILO; SI R1 Y R2 ESTAN CONTIGUOS SON -CH=CH-CH=CH-; R3 ES H, ALQUILO, ALCOXI, HALOGENO, CF3. SON COMPUESTOS PREFERIDOS SAL 4-HIDROXI-O1-[[[6-(4-FENILBUTOXI)-HEXIL]-AMINO]-METIL]-1,3-BENCENODIMETANOL-4-FENILCINAMATO; SAL 4-HIDROXI-O1-[[[6-(4-FENILBUTOXI)-HEXIL]-AMINO]-METIL]-1,3-BENCENODIMETANOL-4-TRIFLUOROMETIL-CINAMATO; SAL 4-HIDROXI-O1-[[[6-(4-FENILBUTOXI)-HEXIL]-AMINO]-METIL]-1,3-BENCENODIMETANOL-4-BENCENODIEMTANOL-3,4-DICLORO-CINAMATO; ENTRE OTROS; EL COMPUESTO TIENE ACTIVIDAD BETAMINERGICA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE ASMA, COPD
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002109243 DE10209243A1 (de) | 2002-03-04 | 2002-03-04 | Neue Arzneimittelkombination zur Inhalation |
| DE2002116124 DE10216124A1 (de) | 2002-04-12 | 2002-04-12 | Neue Zimtsäuresalze, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030933A1 true PE20030933A1 (es) | 2003-12-15 |
Family
ID=27789722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000197A PE20030933A1 (es) | 2002-03-04 | 2003-02-28 | Sales del acido cinamico, procedimientos para su preparacion y su utilizacion como medicamentos |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1483231A1 (es) |
| JP (1) | JP2005519110A (es) |
| AR (1) | AR038622A1 (es) |
| AU (1) | AU2003221482A1 (es) |
| CA (1) | CA2477714C (es) |
| PE (1) | PE20030933A1 (es) |
| TW (1) | TW200404759A (es) |
| UY (1) | UY27686A1 (es) |
| WO (1) | WO2003074469A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2265276B1 (es) * | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8310477D0 (en) * | 1983-04-18 | 1983-05-25 | Glaxo Group Ltd | Chemical compounds |
| ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| US4791108A (en) * | 1987-04-13 | 1988-12-13 | Syntex (U.S.A.) Inc. | Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers |
| IL95590A (en) * | 1989-09-08 | 1996-06-18 | Glaxo Group Ltd | Medicinal preparations containing Salmetrol and Pluticasone Propionate |
| RU2081108C1 (ru) * | 1991-10-16 | 1997-06-10 | Циба-Гейги АГ | Аддитивные соли кислот с основанием и фармацевтическая композиция, обладающая противоопухолевой активностью |
-
2003
- 2003-02-19 CA CA2477714A patent/CA2477714C/en not_active Expired - Fee Related
- 2003-02-19 WO PCT/EP2003/001644 patent/WO2003074469A1/de not_active Ceased
- 2003-02-19 JP JP2003572941A patent/JP2005519110A/ja active Pending
- 2003-02-19 AU AU2003221482A patent/AU2003221482A1/en not_active Abandoned
- 2003-02-19 EP EP03717188A patent/EP1483231A1/de not_active Withdrawn
- 2003-02-27 UY UY27686A patent/UY27686A1/es not_active Application Discontinuation
- 2003-02-28 PE PE2003000197A patent/PE20030933A1/es not_active Application Discontinuation
- 2003-02-28 AR ARP030100660A patent/AR038622A1/es not_active Application Discontinuation
- 2003-03-03 TW TW092104401A patent/TW200404759A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003074469A1 (de) | 2003-09-12 |
| AR038622A1 (es) | 2005-01-19 |
| JP2005519110A (ja) | 2005-06-30 |
| AU2003221482A1 (en) | 2003-09-16 |
| EP1483231A1 (de) | 2004-12-08 |
| UY27686A1 (es) | 2003-10-31 |
| CA2477714C (en) | 2011-01-25 |
| CA2477714A1 (en) | 2003-09-12 |
| TW200404759A (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080359A1 (es) | Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r | |
| PE20091204A1 (es) | Derivados de 2-aminoquinolina como antagonistas del receptor de 5-ht5a | |
| PE20080069A1 (es) | Compuestos biciclicos como agonistas del receptor 40 acoplado a proteina g (gpr40) | |
| PE20080659A1 (es) | Benzotriazoles como moduladores de quinasas | |
| BRPI0818006B8 (pt) | compostos de piperidino-di-hidrotienopirimidinas substituídas, uso dos mesmos e formulações farmacêuticas | |
| PE20080769A1 (es) | Derivados de biaril-sulfonamida | |
| PE20091099A1 (es) | Derivados de aminobenzamida como agentes utiles para controlar parasitos animales | |
| PE20091014A1 (es) | Compuestos espiro y uso farmaceutico de los mismos | |
| PE20141598A1 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| PE20142282A1 (es) | Nuevos derivados de aril-quinolina | |
| AR069607A1 (es) | Inhibidores de la estearoil-coa desaturasa | |
| AR080590A1 (es) | Pirimidinas sustituidas como antagonistas del receptor de la prostaglandina d2 | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| BRPI0409739A (pt) | composto, composição farmacêutica, uso de composto, e, método para o tratamento de uma doença ou de um distúrbio | |
| PE20081388A1 (es) | Derivados de amina como agonistas del adrenoreceptor b2 | |
| UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
| AR042702A1 (es) | Proceso para preparar aripiprazola | |
| PE20120424A1 (es) | Compuestos de quinazolina sustituidos | |
| BR0315995A (pt) | Composto, uso de um composto composição farmacêutica, métodos para a terapia da dor, de distúrbios gastrointestinais, e da ansiedade em um animal de sangue quente, e, processo para preparar um composto | |
| IN2012DN00953A (es) | ||
| PE20081683A1 (es) | Nuevos derivados de sulfonamida | |
| HRP20040943B1 (hr) | Lijek koji sadrži steroide i novi antiholinergik | |
| PE20030933A1 (es) | Sales del acido cinamico, procedimientos para su preparacion y su utilizacion como medicamentos | |
| PE20091735A1 (es) | Derivados del acido 4-dimetilaminobutirico | |
| PE20110675A1 (es) | DERIVADOS DE (FENIL)-AMIDA DEL ACIDO 7-(HETEROCICLO-1-ILMETIL))-1H-INDOL-2 CARBOXILICO COMO INHIBIDORES DE p38 MAP-QUINASA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |